Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ONTY 1.74 -0.05 (-2.79%)
price chart
Oncothyreon Inc (USA) (NASDAQ:ONTY) a Buy: Jefferies
In a research note issued to investors, Biren Amin at Jefferies Initiated their rating on Oncothyreon Inc (USA) (NASDAQ:ONTY) to a Buy.
Oncothyreaon Stock Up 18% On Cancer Drug Deal
Oncothyreon Inc (USA) (NASDAQ:ONTY) stock shot up 18% on Friday after the company announced that its breast cancer drug candidate, ONT-380, a HER2 inhibitor had demonstrated clinical activity and tolerability in previously treated patients in two Phase ...
Oncothyreon makes breast cancer drug deal with Array, stock surges Friday  Puget Sound Business Journal (Seattle) (blog)
Oncothyreon Up on Gaining License to Oncology Candidate  Zacks.com
Related articles »  
Best Biotech Stocks To Buy Now [Neuralstem, Inc., Oncothyreon Inc (USA ...
In fact, Tremblay believes that strong growth in prescription drug sales, growth in FDA drug approvals, increasing orphan drug development, and an aging U.S. population are all reasons to invest in biotech stocks now. Now, penny stock investing is ...
Oncothyreon Inc (USA) (ONTY): Oncothyreon Offers Income To Those Accepting ...
Oncothyreon Inc. (NASDAQ:ONTY) is a biotechnology corporation that dedicates its available resources to treatments for cancer.
Related articles »  
Oncothyreon Inc (USA) (ONTY): Are Hedge Funds Right About This Stock?
Oncothyreon Inc (USA) (NASDAQ:ONTY) was in 9 hedge funds' portfolio at the end of the fourth quarter of 2012. ONTY shareholders have witnessed a decrease in hedge fund interest recently.
Related articles »  
Oncothyreon Inc (USA) (ONTY): You Might Own Oncothyreon For All The Wrong ...
A recently announced collaboration with Array BioPharma (NASDAQ:ARRY) on a small molecule HER2 inhibitor may be the best thing to happen to Oncothyreon (NASDAQ:ONTY) since the company reincorporated in the U.S. six years ago. Oncothyreon ...
Melting Stocks: Wright Medical Group (NASDAQ:WMGI), Oncothyreon (NASDAQ ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) decreased -2.20%, and closed at $1.78.Price to book ratio is 1.78. With recent decline, the year-to-date (YTD) performance reflected a -8.25% decline below last year.
Oncothyreon Inc. (ONTY) in Focus: Stock Rises 6.3%
Oncothyreon Inc. (ONTY - Snapshot Report) was a big mover last session, as the company saw its shares rise over 6% on the day.
Oncothyreon Earnings: An Early Look
Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report, and Oncothyreon (NASDAQ: ONTY ) is about to release its quarterly earnings report. The key to ...
Related articles »  
Why Oncothyreon, Inc. Shares Sank
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »